Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection?

Br J Clin Pharmacol. 1994 Nov;38(5):381-7. doi: 10.1111/j.1365-2125.1994.tb04371.x.

Authors

G F Baxter¹, D M Yellon

Affiliation

¹ Hatter Institute for Cardiovascular Studies, Department of Academic and Clinical Cardiology, University College London Hospitals.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Angioplasty, Balloon, Coronary
Animals
Anticoagulants / administration & dosage
Anticoagulants / pharmacology
Anticoagulants / therapeutic use*
Arrhythmias, Cardiac / prevention & control
Combined Modality Therapy
Coronary Thrombosis / drug therapy
Heart / drug effects
Heart / physiology
Humans
In Vitro Techniques
Myocardial Infarction / mortality
Myocardial Infarction / therapy*
Myocardial Ischemia / etiology
Myocardial Ischemia / physiopathology
Myocardial Ischemia / prevention & control*
Reperfusion Injury / drug therapy
Reperfusion Injury / prevention & control
Reperfusion Injury / therapy

Substances

Anticoagulants